Our previous study had confirmed that ATG9B-4 could promote the malignant characteristics of liver cancer cells by up-regulating the expression of CDK5.[10] And the above study also concluded that ATG9B-4 accelerated the proliferation and migration by down-regulating the expression of ARNTL. Here, CDK5 is linked to liver cancer.